Assyro AI

Orange Book product · Brand (NDA)

DYLOJECT

DICLOFENAC SODIUM

Brand (NDA)NDA 022396DISCN JAVELIN PHARMS INC

At a glance

Dec 23, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 23, 2014

    11 yr 8 mo ago

  2. Today

  3. Patent 8946292 expires

    Listed method-of-use patent (U-1659) expiration.

    Mar 22, 2027

    in 9 mo

Pharmaceutical detail

Active ingredient

DICLOFENAC SODIUM

Strength

37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 022396

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8946292Mar 22, 2027in 9 mo
U-1659
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.